CEO, NetraMark Corp
Dr. Joseph Geraci is the CEO of NetraMark Corp which is a start-up specializing in optimizing clinical trials and drug repurposing/resurrection for age related diseases and oncology. Their technology accomplishes this by cracking open complex patient populations via a new way to perform explainable machine learning. The NetraAI technology is capable of providing novel insights into disease subtypes and it explains the driving mechanisms. The resulting insights are providing a new taxonomy of disease that can transform the way we discover/create therapeutics.
Dr. Geraci holds a PhD in mathematical physics and postdocs in oncology, machine learning, and neuro-psychiatry.